Month: September 2026

Designation, together with a permanent HCPCS code effective October 1, 2026, supports patient access and reimbursement for PYLARIFY TruVu, Lantheus’ PSMA PET imaging agent

BEDFORD, Mass., Sept. 30, 2026 (GLOBE NEWSWIRE) — Lantheus Holdings, Inc. (“Lantheus” or the “Company”) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver better patient outcomes, today announced that the Centers for Medicare & Medicaid Services (“CMS”) has granted Transitional Pass-Through (“TPT”) payment status for PYLARIFY^® TruVu™ (piflufolastat F18) injection, effective October 1, 2026. The designation enables separate reimbursement for PYLARIFY TruVu in the hospital outpatient setting and is intended to support access to innovative diagnostic radiopharmaceuticals for Medicare beneficiaries.

PYLARIFY TruVu is a new formulation of Lantheus’ F 18 prostate-specific membrane antigen (“PSMA”)-targeted PET imaging agent. PYLARIFY TruVu is indicated for positron emission tomography (“PET”) imaging of PSMA positive lesions in men with prostate cancer with suspected metastasis who are candidates for initial definitive therapy or suspected recurrence based on elevated serum prostate-specific antigen (PSA) level. In addition to receiving TPT status, PYLARIFY TruVu has been assigned a permanent Healthcare Common Procedure Coding System (“HCPCS”) code, effective October 1, 2026, facilitating billing and reimbursement for providers. Together, these milestones support patient access to PYLARIFY TruVu.

“The granting of Transitional Pass-Through status for PYLARIFY TruVu marks an important milestone as we prepare for commercial launch and the next phase of growth for our PSMA PET franchise,” said Amanda Morgan, Chief Commercial Officer of Lantheus. “Building on the proven clinical utility and broad adoption of PYLARIFY, this designation supports and enables patient access to advanced PSMA PET imaging. As we move toward a phased geographic rollout, PYLARIFY TruVu’s advantages have the potential to increase supply flexibility and expand geographic reach, helping us serve more patients while ensuring a seamless transition for customers.”

More than 900,000 patients have received a PSMA PET scan with PYLARIFY since the FDA granted approval in May 2021. Building on that foundation, PYLARIFY TruVu was developed to maintain the proven diagnostic characteristics of PYLARIFY while introducing formulation enhancements designed to improve manufacturing efficiency, increase supply flexibility and support broader geographic reach. These enhancements have the potential to enable larger batch sizes at select manufacturing facilities and support access for more patients. Lantheus expects to introduce PYLARIFY TruVu through a phased geographic rollout to support a seamless transition for customers.

About Prostate Cancer
Prostate cancer is the second most common form of cancer affecting men in the U.S. An estimated 1 in 8 men will be diagnosed in their lifetime. The incidence rate for prostate cancer has been increasing since 2014 at a rate of 3% per year overall. For 2026, estimates suggest nearly 334,000 new cases and more than 36,000 deaths. Prostate cancer can be a serious disease and is the second-leading cause of cancer death in men (behind lung cancer), but most men diagnosed with prostate cancer do not die from it. In fact, more than 3.5 million men in the U.S. consider themselves prostate cancer survivors.¹

PYLARIFY TruVu^TM (piflufolastat F 18) Injection
PYLARIFY TruVu^TM (piflufolastat F 18) injection (also known as ¹⁸F-DCFPyL or PyL) is a fluorinated small molecule PSMA-targeted PET imaging agent that enables visualization of lymph nodes, bone and soft tissue metastases to determine the presence or absence of recurrent and/or metastatic prostate cancer.^2,3

PYLARIFY TruVu was developed to build on the success of PYLARIFY^®, the number one utilized PSMA PET imaging agent in the U.S. which has been used in over 900,000 scans across 48 states, Puerto Rico and Washington, D.C.⁴

INDICATION 
PYLARIFY^® (piflufolastat F 18) and PYLARIFY TRUVU^TM (piflufolastat F 18) Injection are indicated for positron emission tomography (PET) of prostate-specific membrane antigen (PSMA) positive lesions in men with prostate cancer: 

• with suspected metastasis who are candidates for initial definitive therapy. 
• with suspected recurrence based on elevated serum prostate-specific antigen (PSA) level. 
   

IMPORTANT SAFETY INFORMATION

WARNINGS AND PRECAUTIONS 
Risk of Image Misinterpretation 
Imaging interpretation errors can occur with PYLARIFY and PYLARIFY TRUVU imaging. A negative image does not rule out the presence of prostate cancer and a positive image does not confirm the presence of prostate cancer. The performance of PYLARIFY and PYLARIFY TRUVU for imaging biochemical evidence of recurrence of prostate cancer seems to be affected by serum PSA levels. The performance of PYLARIFY and PYLARIFY TRUVU for imaging of metastatic pelvic lymph nodes prior to initial definitive therapy seems to be affected by risk factors such as Gleason score and tumor stage. PYLARIFY and PYLARIFY TRUVU uptake is not specific for prostate cancer and may occur with other types of cancer as well as non-malignant processes and in normal tissues. Clinical correlation, which may include histopathological evaluation, is recommended. 

Hypersensitivity Reactions
Monitor patients for hypersensitivity reactions, particularly those with a history of allergy to other drugs and foods. Reactions may be delayed. Always have trained staff and resuscitation equipment available. 

Radiation Risks 
PYLARIFY and PYLARIFY TRUVU, expose patients to radiation. Radiation exposure is associated with a dose-dependent increased risk of cancer. Ensure safe handling and preparation procedures to protect patients and health care workers from unintentional radiation exposure. Advise patients to hydrate before and after administration and to void frequently after administration.

ADVERSE REACTIONS 
The most frequently reported adverse reactions were headaches, dysgeusia and fatigue, occurring at rate of ≤2% during clinical studies. In addition, a delayed hypersensitivity reaction was reported in one patient (0.2%) with a history of allergic reactions. 

DRUG INTERACTIONS 
Androgen deprivation therapy (ADT) and other therapies targeting the androgen pathway, such as androgen receptor antagonists, may result in changes in uptake of PYLARIFY and PYLARIFY TRUVU in prostate cancer. The effect of these therapies on performance of PYLARIFY and PYLARIFY TRUVU PET has not been established. 
 
To report suspected adverse reactions for PYLARIFY or PYLARIFY TRUVU, call 1-800-362-2668 or contact FDA at 1-800-FDA-1088 or www.fda.gov/medwatch. Please see the full Prescribing Information for PYLARIFY and PYLARIFY TRUVU.

Safe Harbor for Forward-Looking and Cautionary Statements
This press release contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, as amended, that are subject to risks and uncertainties and are made pursuant to the safe harbor provisions of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements may be identified by their use of terms such as “can,” “continue,” “designed,” “enables,” “enhance,” “ensuring,” “expects,” “improve,” “intended,” “next chapter,” “phased,” “potential,” “prepare,” “priority,” “transition,” “will,” “work” and other similar terms. Such forward-looking statements are based upon current plans, estimates and expectations that are subject to risks and uncertainties that could cause actual results to materially differ from those described in the forward-looking statements. The inclusion of forward-looking statements should not be regarded as a representation that such plans, estimates and expectations will be achieved. Readers are cautioned not to place undue reliance on the forward-looking statements contained herein, which speak only as of the date hereof. Lantheus undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future developments or otherwise, except as may be required by law. Risks and uncertainties that could cause our actual results to materially differ from those described in the forward-looking statements include (i) our ability to complete the technology transfer across our PET manufacturing facilities (“PMF”) network for PYLARIFY TruVu and to obtain FDA approval for each PMF to manufacture PYLARIFY TruVu in accordance with our planned rollout plan and without disruption to our supply chain; (ii) our ability to have payers add HCPCS coding to their systems on a timely basis and to have customers adopt PYLARIFY TruVu; (iii) the ability of our PMF network to supply PYLARIFY TruVu to the market; (iv) the ability of PMF sites with high‑energy cyclotrons to increase batch sizes or to reach more patients and serve broader geographic markets; (v) the intellectual property protection of PYLARIFY TruVu; and (vi) the risk and uncertainties discussed in our filings with the Securities and Exchange Commission (including those described in the Risk Factors section in our Annual Reports on Form 10-K and our Quarterly Reports on Form 10-Q).

About Lantheus
Lantheus is the leading radiopharmaceutical-focused company, delivering life-changing science to enable clinicians to Find, Fight and Follow disease to deliver better patient outcomes. Headquartered in Massachusetts with offices in New Jersey, Canada, Germany, Sweden, Switzerland and the United Kingdom, Lantheus has been providing radiopharmaceutical solutions for 70 years. For more information, visit www.lantheus.com.

Contacts:
Lantheus
Mark Kinarney
Vice President, Investor Relations
978-671-8842
ir@lantheus.com

Melissa Downs
Executive Director, External Communications
646-975-2533
media@lantheus.com

Multimedia assets for media are available here.

¹American Cancer Society. Cancer Facts & Figures 2026. Atlanta: American Cancer Society; 2026.
²Pienta KJ, Gorin MA, Rowe SP, et al. A phase 2/3 prospective multicenter study of the diagnostic accuracy of prostate specific membrane antigen PET/CT with 18F-DCFPyL in prostate cancer patients (OSPREY). J Urol. 2021;206(1):52-61.
³Morris MJ, et al; CONDOR Study Group. Diagnostic Performance of 18F-DCFPyL-PET/CT in Men with Biochemically Recurrent Prostate Cancer: Results from the CONDOR Phase III, Multicenter Study. Clin Cancer Res. 2021 Jul 1;27(13):3674-3682. doi: 10.1158/1078-0432.CCR-20-4573. Epub 2021 Feb 23. PMID: 33622706; PMCID: PMC8382991.
⁴Data on file.

Industry-leading inventory depth, expansive retail reach, and a growth-focused approach are helping independent labels maximize the value of every release and every catalog

PLANTATION, Fla., Sept. 30, 2026 (GLOBE NEWSWIRE) — AMPED Distribution, a division of Alliance Entertainment (NASDAQ: AENT), continues to redefine what independent labels should expect from a distribution partner. By combining sales, marketing, data analytics, inventory management, retail strategy, and supply chain expertise, AMPED delivers a comprehensive growth platform designed to maximize visibility, drive demand, and create long-term value across both physical and digital channels.

At a time when physical music continues to outperform expectations, labels need a partner capable of moving quickly, maintaining product availability, and capitalizing on opportunities wherever music fans shop. AMPED’s momentum has translated into significant business growth, with Fiscal Year 2026 sales reaching 46% year-over-year growth. These results underscore the increasing demand for a distribution partner capable of delivering scale, reach, and execution across today’s music marketplace.

“True independent music distribution success goes well beyond release day,” said Dean Tabaac, Head of AMPED Distribution. “It requires a complete growth platform designed to maximize reach and elevate independent artists and their record labels. By combining industry-leading inventory depth with seasoned expertise, AMPED connects artists and their labels with opportunities wherever music fans are ready to buy.”

“We partnered with AMPED a little over a year ago to help us deliver best in class service and results to the independent artist and label community. Vinyl records and CDs, along with the record store experience, is critical to artist development and a huge priority for Virgin Music Group. The partnership has been tremendous, and VMG will finish 2026 with record results in the U.S.”
-Zack Gershen, Global Head of Commercial Marketing

More than a music distributor, AMPED serves as an extension of its label partners’ teams. The company supports every stage of the product lifecycle, from release planning and retail placement to marketing execution, inventory management, demand forecasting, and sales strategy. This integrated approach enables labels to scale efficiently while benefiting from a partner focused on delivering measurable results.

A key differentiator is AMPED’s commitment to maximizing both frontline releases and catalog performance. While the company consistently executes impactful launch campaigns for new releases, it remains equally focused on helping labels create long-term value from their catalogs. AMPED understands that catalogs must be worked, not just made available to maximize their profitability. Through retailer programs, sales initiatives, merchandising opportunities, marketing campaigns, tour support and other promotional activations AMPED helps keep catalog titles visible and available long after their initial release.

Backed by Alliance Entertainment’s cutting-edge fulfillment infrastructure, AMPED helps labels maintain strong in-stock positions and broad product availability across retail and e-commerce channels. This inventory depth, combined with extensive retail relationships, helps ensure products are available whenever and wherever consumers are ready to buy.

Supporting these efforts is a team of seasoned professionals across sales, data, marketing, and inventory management. This group of people, yes, real people, are known and respected industry wide. Working collaboratively and independently, these teams provide the expertise, operational support, and marketplace knowledge needed to help labels navigate an increasingly dynamic industry.

Simply put, AMPED offers labels a comprehensive distribution platform designed to support growth across physical and digital channels. From launch planning and catalog development to inventory management and retail execution, AMPED remains committed to helping labels expand their reach, connect with consumers, and build long-term success.

About AMPED Distribution

Founded in 2013, AMPED Distribution, a division of Alliance Entertainment, provides independent labels and artists with comprehensive physical and digital distribution, sales, marketing, and technology services. Leveraging Alliance Entertainment’s fulfillment network, retail relationships, and operational infrastructure, AMPED supports releases across major retailers, independent record stores, specialty outlets, and leading e-commerce platforms.

Through a combination of sales expertise, marketing support, inventory management, retail strategy, and data-driven insights, AMPED helps labels expand reach, strengthen fan engagement, maximize catalog value, and drive sustainable growth. Whether launching a new release or supporting long-term catalog opportunities, AMPED serves as a strategic partner dedicated to helping labels succeed in today’s evolving music marketplace.

About Alliance Entertainment

Alliance Entertainment (NASDAQ: AENT) is a scaled entertainment commerce and collectibles platform serving content owners, brands, retailers and fans across music, movies, gaming, licensed merchandise and collectibles. The Company also owns and develops proprietary brands and platforms, including Handmade by Robots™ and Alliance Authentic™, while Endstate Authentic adds NFC-enabled authentication and digital product identity capabilities supporting provenance, brand protection and authenticated resale. Leveraging decades of industry relationships and distribution, fulfillment and inventory-management expertise, Alliance reaches more than 35,000 retail and e-commerce storefronts, connecting entertainment franchises and collectible products with consumers across channels and generations.

For more information, visit www.aent.com.

Forward Looking Statements

Certain statements included in this Press Release that are not historical facts are forward-looking statements for purposes of the safe harbor provisions under the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements generally are accompanied by words such as “believe,” “may,” “will,” “estimate,” “continue,” “anticipate,” “intend,” “expect,” “should,” “would,” “plan,” “predict,” “potential,” “seem,” “seek,” “future,” “outlook,” and similar expressions that predict or indicate future events or trends or that are not statements of historical matters. These forward-looking statements include, but are not limited to, statements regarding estimates and forecasts of other financial and performance metrics and projections of market opportunity. These statements are based on various assumptions, whether identified in this Press Release, and on the current expectations of Alliance’s management and are not predictions of actual performance. These forward-looking statements are provided for illustrative purposes only and are not intended to serve as and must not be relied on by an investor as, a guarantee, an assurance, a prediction, or a definitive statement of fact or probability. Actual events and circumstances are difficult or impossible to predict and will differ from assumptions. Many actual events and circumstances are beyond the control of Alliance. These forward-looking statements are subject to a number of risks and uncertainties, including risks relating to the anticipated growth rates and market opportunities; changes in applicable laws or regulations; the ability of Alliance to execute its business model, including market acceptance of its systems and related services; Alliance’s reliance on a concentration of suppliers for its products and services; increases in Alliance’s costs, disruption of supply, or shortage of products and materials; Alliance’s dependence on a concentration of customers, and failure to add new customers or expand sales to Alliance’s existing customers; increased Alliance inventory and risk of obsolescence; Alliance’s significant amount of indebtedness; our ability to refinance our existing indebtedness; risks that a breach of the revolving credit facility could result in the lender declaring a default and that the full outstanding amount under the revolving credit facility could be immediately due in full, which would have severe adverse consequences for the Company; known or future litigation and regulatory enforcement risks, including the diversion of time and attention and the additional costs and demands on Alliance’s resources; Alliance’s business being adversely affected by increased inflation, uncertainty regarding tariffs, higher interest rates and other adverse economic, business, and/or competitive factors; geopolitical risk and changes in applicable laws or regulations; as well as our financial condition and results of operations; substantial regulations, which are evolving, and unfavorable changes or failure by Alliance to comply with these regulations; product liability claims, which could harm Alliance’s financial condition and liquidity if Alliance is not able to successfully defend or insure against such claims; availability of additional capital to support business growth; and the inability of Alliance to develop and maintain effective internal controls.

Media Contact

Jocelynn Pryor
VP of Marketing, AMPED Distribution
Jocelynn@AMPEDDistribution.com
949-225-1170 Ext. 3411
www.AMPEDDistribution.com

For investor inquiries, please contact:

Dave Gentry
RedChip Companies, Inc.
1-800-REDCHIP (733-2447)
1-407-644-4256
AENT@redchip.com

Mississippi Expansion and Oklahoma Fleet Upgrade Expected to Increase Active Mining Hash Rate 25% to Approximately 964 PH/s

TAMPA, Fla., Sept. 30, 2026 (GLOBE NEWSWIRE) — PowerCompute, Inc. (Nasdaq: PWCM) (“PowerCompute” or the “Company”), today announced that its wholly owned subsidiary, US Digital Mining and Hosting Co., LLC, has fully repaid and terminated its Bitcoin-backed credit facility with ChainFi, Inc. d/b/a Arch Lending, satisfying approximately $22.45 million of obligations and releasing all remaining Bitcoin collateral. No Bitcoin remains pledged.

Transaction and Operating Highlights

• Bitcoin-backed credit facility fully repaid and terminated. No Bitcoin remains pledged.
• Total secured debt reduced from approximately $19.4 million at June 30, 2026 to approximately $1.25 million, a reduction of approximately 94%. Remaining secured borrowings consist of a single secured promissory note maturing December 31, 2026, none of which is secured by Bitcoin.
• Approximately 39.6 Bitcoin, valued at approximately $3.3 million, returned to the Company.
• Approximately 3.5 MW of owned, interconnected electrical capacity in Mississippi, not yet energized, targeted for incremental Bitcoin mining.
• Columbus expansion and continued Calumet fleet modernization expected to increase active mining hash rate from approximately 771 PH/s as of June 30, 2026 to a forecasted increase of approximately 964 PH/s, an increase of approximately 25%.
• 26 MW of owned, interconnected electrical capacity at a blended power cost, net of power sales, of approximately 3.3 cents per kilowatt-hour.
• On completion of the planned deployments, the Company’s 26 MW of owned capacity would support approximately 964 PH/s, or approximately 37 PH/s per megawatt.

Facility Repayment and Debt Reduction

The Arch credit facility was settled on September 24, 2026, its scheduled reset date. Under the credit facility’s settlement provisions, Arch sold approximately 267.3 of the 307 pledged Bitcoin to satisfy $21,892,132 of principal, $118,582 of accrued interest and a $440,122 fee, and returned the remaining approximately 39.6 Bitcoin to PowerCompute.

The credit facility was non-recourse and contained no margin-call or price-triggered liquidation provisions. It was settled on its scheduled reset date, not as a result of a margin call or forced liquidation.

With this repayment, PowerCompute has reduced total secured debt from approximately $19.4 million as of June 30, 2026, as reported in the Company’s June 30, 2026 Form 10-Q, to approximately $1.25 million — a reduction of approximately 94% in approximately three months. The Company’s remaining secured borrowings consist of a single secured promissory note maturing December 31, 2026. None of the Company’s remaining borrowings is secured by Bitcoin.

The Arch credit financing ultimately refinanced debt used to build PowerCompute’s mining operations. Approximately $12 million of the original debt funded the acquisition of the Company’s Oklahoma and Mississippi mining sites, with additional proceeds used to purchase miners and mining equipment, repair and refurbish mining equipment, and for other corporate purposes.

Repayment of the Arch credit facility eliminates the interest expense and collar-related expense associated with the Arch credit facility, the prior Galaxy credit facility and the Liebel loans. PowerCompute intends to use Bitcoin as working capital to fund equipment purchases, operating requirements and growth initiatives rather than accumulate Bitcoin through a leveraged treasury strategy.

“Repaying the secured debt lowers our annual interest expense to approximately $140 thousand for our remaining secured debt on a annual basis and eliminates the annual interest expense and the collar-related expense that came with the prior Galaxy and Arch credit facilities,” said Richard Russell, Chief Financial Officer of PowerCompute. “We have reduced total debt by approximately 94% in approximately three months, from $19.4 million to approximately $1.25 million, and none of our Bitcoin remains pledged as collateral. That is a materially simpler capital structure and allows us to direct more capital toward productive mining assets instead of debt service.”

As of September 25, 2026, PowerCompute held approximately 62 Bitcoin, valued at approximately $5.2 million based on a Bitcoin price of approximately $84,500 as of that date.

Capital Deployment and Mining Expansion

At Columbus, Mississippi, PowerCompute plans to deploy new mining equipment across approximately 3.5 MW of electrical capacity that is owned and interconnected but not yet energized. Because the Company already owns the underlying electrical infrastructure, the planned deployment would add incremental hash rate without acquiring an additional mining site.

At Calumet, Oklahoma, the Company intends to continue replacing older miners with newer, more energy-efficient equipment, building upon the fleet modernization program announced earlier this month.

PowerCompute currently operates at approximately 763 PH/s of active mining hash rate as of August 31, 2026. Upon completion of the planned Columbus expansion and continued Calumet fleet modernization, the Company expects active mining hash rate to increase to approximately 964 PH/s.

This would represent an increase of approximately 201 PH/s, or approximately 21%, from the Company’s August 31, 2026 active hash rate, and would equate to approximately 37 PH/s for every megawatt of the Company’s owned capacity, while also reducing average fleet energy consumption per terahash.

“What we own and HODL is power,” said Bruce M. Rodgers, Chairman, Chief Executive Officer and President of PowerCompute. “We own 26 megawatts of interconnected electrical capacity at a blended net cost of approximately 3.3 cents per kilowatt-hour. We have taken out our Bitcoin-backed debt and we are putting capital back into productive assets — more mining capacity in Mississippi and more efficient machines in Oklahoma. Bitcoin mining and HPC are two ways to monetize the same megawatt, and we intend to direct our power toward the use that generates the highest return.”

Power, Bitcoin Mining and HPC

PowerCompute owns 26 MW of interconnected electrical capacity: 15 MW at Calumet, Oklahoma and 11 MW at Columbus, Mississippi. At this time, approximately 22.5 MW primarily supports Bitcoin mining, with a portion allocated to an enterprise HPC pilot program. Both locations are mining data centers developed around electrical capacity the Company owns outright.

The Company views Bitcoin mining and high-performance computing (“HPC”) and artificial intelligence (“AI”) applications as alternative ways to monetize its electrical infrastructure. Bitcoin mining can monetize available power immediately and can be curtailed rapidly when power sales are more economically attractive. HPC and AI workloads can potentially generate higher revenue per megawatt but require sustained uptime, additional infrastructure and customers.

Following repayment of the Arch credit facility, PowerCompute will no longer pursue a leveraged Bitcoin treasury strategy. The Company intends to focus capital on acquiring and monetizing low-cost electrical infrastructure, increasing Bitcoin mining production and efficiency, and developing HPC and AI computing capacity.

About PowerCompute

PowerCompute, Inc. (Nasdaq: PWCM), formerly LM Funding America, Inc., is an owner and operator of electrical infrastructure that converts electricity into Bitcoin and high-performance computing and artificial intelligence capacity. Founded in 2008 and headquartered in Tampa, Florida, the Company operates 26 megawatts of wholly owned, interconnected electrical infrastructure across data center facilities in Oklahoma and Mississippi.

The Company also operates a technology-enabled specialty finance business providing funding to nonprofit community associations primarily in Florida. For more information, please visit https://www.power-compute.com.

Forward-Looking Statements

This press release may contain forward-looking statements made pursuant to the Private Securities Litigation Reform Act of 1995. Words such as “anticipate,” “believe,” “estimate,” “expect,” “intend,” “plan,” and “project” and other similar words and expressions are intended to signify forward-looking statements. Forward-looking statements are not guarantees of future results and conditions but rather are subject to various risks and uncertainties.

Some of these risks and uncertainties are identified in the Company’s most recent Annual Report on Form 10-K and its other filings with the SEC, which are available at www.sec.gov. These risks and uncertainties include, without limitation, the Company’s ability to maintain compliance with the continued listing requirements of The Nasdaq Stock Market, including the minimum bid price requirement; the Company’s ability to apply the returned collateral as intended; the availability, cost and timely delivery and installation of mining equipment and related infrastructure, including the effect of tariffs on imported equipment; the Company’s ability to increase active mining hash rate or realize anticipated improvements in fleet efficiency; the Company’s ability to energize remaining power capacity on anticipated timelines or at anticipated cost; the Company’s ability to repay or refinance its remaining indebtedness at or before maturity; changes in Bitcoin prices, Bitcoin network difficulty and total network hash rate; the availability and pricing of energy sales and curtailment revenue; the Company’s ability to convert owned power capacity to HPC and AI use on anticipated timelines or at anticipated cost; the Company’s ability to acquire additional electrical capacity on acceptable terms; the Company’s ability to secure customers for HPC and AI capacity; the anticipated reduction in interest and collar-related expense following repayment of the Arch facility; the availability and cost of GPU and related infrastructure equipment; competition in the HPC and AI compute market; and other risks associated with the Company’s Bitcoin mining, HPC, AI and specialty finance businesses.

The occurrence of any of these risks and uncertainties could have a material adverse effect on the Company’s business, financial condition and results of operations. Forward-looking statements speak only as of the date made, and the Company undertakes no obligation to update such statements except as required by applicable law.

Investor and Media Contact
KCSA Strategic Communications
Philip Carlson
pwcm@kcsa.com
212-896-1233

Contract covers high-performance alloys and precision wire used in the production of jet engine components

Award is in addition to the $2 billion DLA tungsten stockpile contract announced September 14, 2026

Further strengthens Elmet’s role as a domestic supplier of critical materials to domestic ADG markets

LEWISTON, Maine, Sept. 30, 2026 (GLOBE NEWSWIRE) — Elmet Technologies, a wholly owned subsidiary of The Elmet Group Co. (NASDAQ: ELMT) (“ELMT” or the “Company”), today announced it has been awarded a contract valued at approximately $36 million by the Defense Logistics Agency (“DLA”) to supply high-performance molybdenum and tungsten alloys and precision wire to the U.S. National Defense Stockpile. These materials are used in the production of jet engine components and other demanding aerospace applications. The award is separate from the $2 billion DLA contract announced on September 14, 2026.

Molybdenum and tungsten, known as refractory metals, withstand temperatures that would melt most other metals, which makes them essential to jet engines and other high-performance defense systems. Global supply of these metals has historically been concentrated outside the United States, which makes a reliable domestic source a national priority.

Under the contract, Elmet Technologies will supply DLA Strategic Materials, the agency responsible for managing the National Defense Stockpile, with titanium-zirconium-molybdenum (“TZM”) alloy billets, bar stock, and ingots, as well as specialized molybdenum and tungsten wire.

TZM is a molybdenum alloy strengthened with small additions of titanium and zirconium. It retains its strength at higher temperatures than pure molybdenum, making it well suited to aerospace and defense applications where materials must perform under extreme heat and stress.

“This award reflects the depth of Elmet Technologies’ capabilities in molybdenum and tungsten, from specialty alloy billets and bar to precision ultra-fine wire with advanced properties,” said Derek Fox, President of the Critical Materials Components Division of The Elmet Group. “Refractory metals are foundational to aerospace manufacturing and the production of jet engine components. As a vertically integrated U.S. manufacturer, we believe this contract further demonstrates our role as a trusted domestic source of critical materials and precision-engineered components.”

The award draws on Elmet Technologies’ metallurgical engineering capabilities in tungsten and molybdenum, from powder through finished mill products and components, which have supported customers in aerospace, defense, and other critical industries for nearly a century. Capabilities reflected in the contract include:

• Precision refractory metal wire. Specialized wire produced from molybdenum, tungsten, and related alloys, including potassium-doped grades, manufactured to tight dimensional, electrical, and mechanical specifications.
• High-strength TZM billets. Large-format TZM billets produced by both press-and-sinter and arc-cast processes.
• High-performance refractory alloy bar. Extruded bar produced by both arc-cast and press-and-sinter processes for high strength at extreme temperatures.
• Arc-cast refractory alloy ingots. Produced by arc-cast melting under controlled conditions, providing dense, high-purity feedstock for further forming.

Collectively, these products reflect Elmet Technologies’ ability to produce refractory metal materials across multiple forms and processes, from large-format alloy billets to precision ultra-fine wire.

Building on Recent Momentum with the DLA and Department of War

On September 14, 2026, The Elmet Group announced a $450 million committed investment from the United States Department of War. At the same time, it announced that Elmet Technologies had been awarded an indefinite delivery/indefinite quantity (“IDIQ”) contract by the DLA to support the rebuilding of the National Defense Stockpile. That contract has a ceiling value of $2 billion, including a guaranteed funded commitment of $150 million, and covers the supply of tungsten concentrates and sodium tungstate to the National Defense Stockpile.

Building on recent announcements focused on the Company’s efforts to secure upstream tungsten supply through mining, offtake, and refining relationships, this award demonstrates the downstream value of that supply that can be realized in the form of finished, high-value refractory metal products manufactured in the United States. Together, these developments advance ELMT’s objective of establishing an integrated critical materials supply chain from ore to finished component.

About Elmet Technologies
Elmet Technologies is the only U.S.-owned and operated, vertically integrated tungsten and molybdenum manufacturer. Since 1929, the company has been proudly serving its customers and applications in aerospace, defense, government, industrial, medical, semiconductor, electronics, and energy. With nearly 400 employees across three facilities, totaling over 500,000 square feet in Maine, Ohio, and Michigan, it is now one of the largest U.S.-owned producers of tungsten and molybdenum materials and products, fabricating materials to its global customers’ most exacting specifications. Elmet Technologies is ISO9001, AS9100, and ITAR registered.

About The Elmet Group
The Elmet Group is a U.S.-based provider of critical materials, precision-engineered components, and advanced high-energy systems for the Aerospace, Defense and Government, Industrial, Medical, Semiconductor and Electronics, and Energy industries. The Company operates through three divisions: Critical Materials Components (CMC), Engineered Microwave Products (EMP), and Elmet Refining & Trading (ERT), leveraging materials science and precision engineering expertise to deliver high-performance solutions. The Elmet Group is dedicated to strengthening domestic manufacturing capabilities to support the U.S. and its Allies’ needs in both critical materials and advanced high-power microwave systems.

Media Contact
media@theelmetgroup.com

Investor Contact
Tom Colton and Greg Bradbury
Gateway Group, Inc.
ELMT@gateway-grp.com
949-574-3860

Forward-looking statements disclaimer
The information in this press release includes forward-looking statements within the meaning of the federal securities laws, including the Private Securities Litigation Reform Act of 1995. These statements generally relate to future events or our future financial or operating performance and include statements regarding (i) the $36 million contract awarded to ELMT by the DLA for the supply of high-performance molybdenum and tungsten alloys and precision wire, (ii) the ability of ELMT to strengthen its position as a domestic supplier of critical materials to ADG and other markets; (iii) the ability of ELMT to become a vertically integrated, U.S.-based provider of critical materials with capabilities and access throughout the full Tungsten supply chain across key geographies around the world; (iv) the ability of ELMT to successfully supply critical materials under its contracts with the DLA; (v) the ability of ELMT to realize downstream value from its efforts to secure a domestic critical materials supply chain; and (vi) ELMT’s future performance, expected outcomes and strategic initiatives.

When used in this press release, words such as “expect,” “project,” “estimate,” “believe,” “anticipate,” “intend,” “plan,” “seek,” “forecast,” “target,” “predict,” “may,” “should,” “would,” “could,” and “will,” the negative of these terms and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain such identifying words. Forward-looking statements are based on management’s current expectations and assumptions, and are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict. As a result, actual results could differ materially from those indicated in these forward-looking statements. When considering these forward-looking statements, you should keep in mind the risk factors and other cautionary statements in ELMT’s Registration Statement on Form S-1, as amended (File No. 333-294725) and subsequent filings ELMT makes with the Securities and Exchange Commission. ELMT undertakes no obligation and does not intend to update these forward-looking statements to reflect events or circumstances occurring after this press release. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release.

Expansion combines ibott’s deep AV and digital-economy expertise with the breadth and capabilities of Skyward Group to deliver more complete solutions for emerging mobility risks

HOUSTON, Sept. 30, 2026 (GLOBE NEWSWIRE) — Skyward Group (Nasdaq: SKWD) (“the Group” or “the Company”), the unified specialty insurance organization whose operating businesses include Skyward Specialty Insurance Group, Inc.^® (“Skyward Specialty”) and Apollo Group Holdings Ltd. (“Apollo”), announced today it is expanding ibott’s autonomous vehicle (AV) expertise directly to the U.S. primary market, adding a complete suite of solutions and products for customers across AV ecosystems.

AV mobility creates a fundamentally different risk landscape, with exposures expanding across multiple participants including vehicle manufacturers, autonomous driving system developers and fleet operators. Rather than apply traditional insurance models to these emerging risks, ibott brings more than a decade of specialized experience developing solutions designed around the unique and interconnected exposures of the autonomy and digital economies. The deep industry expertise, data driven approach and understanding of evolving business markets enable ibott to help customers navigate risks that are changing with the technology itself.

“We believe the future of autonomous vehicles and their continued expansion and adoption requires insurance that is built around how these businesses actually operate,” said Chris Moore, chief underwriting officer, ibott. “Our experience in the AV and digital economy markets give us a differentiated perspective and approach for the risks customers are navigating and we can create a solution specific to the customer’s needs. With access to the broader capabilities of Skyward Group, we can extend our expertise into the primary market and provide a more complete insurance solution from the ground up.”

Bringing ibott’s capabilities into the U.S. primary market also expands the range of solutions available to customers, providing greater flexibility to address their insurance needs across the risk spectrum. By connecting the specialized underwriting, technology, and data expertise to the distribution capabilities and market access across the Skyward Group organization, ibott is positioned to broaden and further diversify its portfolio.

“ibott was built to insure businesses operating at the intersection of technology, data and new business models and has the relationships and expertise to understand this complex ecosystem. Autonomous mobility risks are moving rapidly from innovation to commercialization and the insurance industry needs to evolve alongside it at speed,” said Andrew Robinson, chairman & chief executive officer of Skyward Group. “This is where Skyward Group excels. We leverage the specialized expertise, innovation and capabilities of both Skyward Specialty and Apollo to stay ahead of these emerging risks in the rapidly evolving digital economy, AV and embedded insurance landscape.”

About Skyward Group
Skyward Group (Nasdaq: SKWD) is the holding company brand for its U.S. and U.K. businesses, Skyward Specialty Insurance Group, Inc.^® and Apollo Holding Group, respectively, delivering a comprehensive suite of specialized insurance solutions across global specialty property and casualty markets. Focused on the specialty industry’s most niche, complex risks of today and the emerging challenges of tomorrow, Skyward Group leverages the forward-looking insight and disciplined execution of each organization to drive sustainable growth and long-term value for its shareholders, distribution partners and other stakeholders. For more information about Skyward Group, Skyward Specialty and Apollo, please visit skywardgroup.com.

About Apollo
Apollo, a Skyward Group company, is an innovation-inspired insurance platform operating at Lloyd’s of London, offering data-driven and creative solutions to a wide variety of risks. Apollo provides high quality products and services to clients, brokers and capital partners, enabling a resilient and sustainable world. Apollo offers products across Property, Casualty, Marine, Energy & Transportation, Specialty, Reinsurance, as well as Smart Follow and digital & embedded risk programs. Apollo’s experience and unique ecosystem give Platform Partners the best chance of success through the Lloyd’s new entrant process to the delivery of their long-term strategy. For more information about Apollo, please visit apollounderwriting.com.

About ibott
Ibott, part of Apollo, a Skyward Group company, is a specialist underwriting business focused on the risks of the digital economy and emerging industries. Combining underwriting expertise with data, technology and a forward-looking approach to risk, ibott develops innovative insurance solutions for businesses operating in rapidly evolving markets, including new mobility, autonomous vehicles, connected technology and platform-based business models. Ibott works with brokers, clients and partners to create bespoke solutions aligned for the businesses of today and tomorrow. For more information about ibott, please visit apollounderwriting.com/ibott.

Media Contact
Haley Doughty
Skyward Specialty Insurance Group
713-935-4944
hdoughty@skywardinsurance.com

Investor Contact
Jordan Arnold
Skyward Specialty Insurance Group
346-215-0250
jarnold@skywardinsurance.com

Optional Renewals Could Increase Total Contract Value

NEW YORK, Sept. 30, 2026 (GLOBE NEWSWIRE) — AIB Data Centers Inc. (NYSE American: AIB) (“AIB” or the “Company”), a developer and operator of purpose-built data centers for artificial intelligence and high-performance computing, today announced that it has entered into a binding agreement with Nebius (Nasdaq: NBIS), the AI cloud company, for 50 MW of critical IT capacity at AIB’s facility located in the southeastern United States.

AIB expects the customer prepayments under the initial 12-year term, together with project-level debt and preferred equity, to fund a substantial portion of the initial development costs for the 50 MW project, significantly reducing AIB’s anticipated need for corporate-level common equity and limiting potential dilution to shareholders.

The contracted capacity is supported by AIB’s previously announced 15-year Electric Service Agreement for 65 MW of utility load at the site, which requires no significant additional electrical infrastructure upgrades. AIB expects to deliver the capacity in two data halls.

Nebius is a leading AI cloud company, providing full-stack AI infrastructure for developers and enterprises building next-generation applications.

“Signing Nebius represents a transformational milestone for AIB,” said Jerry Tang, Chief Executive Officer of AIB Data Centers. “Our strategy is straightforward: secure power in attractive markets and convert that power into long-term contracted revenue with leading AI infrastructure companies. This agreement validates that strategy. We believe we have a capital-efficient path to develop the initial capacity. Our focus now turns to execution and delivering on schedule.”

“Time-to-power is the binding constraint on AI infrastructure today, and AIB’s existing power position gave us a clear path to bringing this capacity online on a timeline that works for our customers,” said Andrey Korolenko, Chief Product and Infrastructure Officer at Nebius. “This agreement adds dedicated capacity in the southeastern United States for training and inference workloads.”

The agreement follows several recent milestones for AIB, including the completion of a strategic acquisition in Texas that increased the Company’s total contracted power capacity to approximately 120 MW. Supported by an experienced leadership team with backgrounds at AWS, Amazon and Vantage Data Centers, AIB continues to advance its remaining power portfolio and pursue additional long-term agreements with leading AI and high-performance computing customers.

About AIB Data Centers

AIB Data Centers Inc. is a developer and operator of digital infrastructure focused on AI hosting and high-performance computing workloads. The Company’s platform combines access to reliable, scalable power resources with modular infrastructure deployment designed to accelerate the development of next-generation compute capacity.

For more information, visit https://www.aib.us/.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements include, but are not limited to, statements regarding the anticipated completion of the Data Center, the expected commencement of colocation services, the achievement of service-level agreement compliance milestones, the Company’s expected capital structure and financing strategy for the project, including the anticipated use of customer prepayments, project-level debt, and preferred equity, the anticipated impact on the Company’s need for corporate-level common equity and potential dilution to shareholders, and the opportunity to expand capacity at the campus. Forward-looking statements are generally identified by words such as “anticipate,” “believe,” “could,” “estimate,” “expect,” “intend,” “may,” “plan,” “potential,” “predict,” “project,” “should,” “will,” “would,” and similar expressions, although not all forward-looking statements contain these identifying words. These forward-looking statements are based on the Company’s current expectations, estimates, and projections about its business and industry, the assumptions of management, and information available as of the date of this press release. Such statements involve known and unknown risks, uncertainties, and other factors that may cause actual results, performance, or achievements to be materially different from those expressed or implied by the forward-looking statements. These factors include, but are not limited to: (i) risks relating to the timely completion and commissioning of the Data Center; (ii) risks related to the Company’s ability to achieve and maintain required service-level standards; (iii) the ability of the parties to satisfy the conditions for release of escrowed funds; (iv) risks related to the financial condition and creditworthiness of Nebius Inc. and its parent, Nebius Group N.V.; (v) changes in the demand for data center and colocation services; (vi) risks related to construction, permitting, and regulatory approvals; (vii) general economic, market, and business conditions; and (viii) other risks and uncertainties described in the Company’s filings with the Securities and Exchange Commission, including the Company’s most recent Annual Report on Form 10-K and subsequent Quarterly Reports on Form 10-Q. The Company cautions investors not to place undue reliance on any forward-looking statements, which speak only as of the date of this press release. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, except as required by applicable law.

AIB Investor Relations:
MZ Group – MZ North America
AIB@mzgroup.us

JACKSONVILLE, Fla., Sept. 30, 2026 (GLOBE NEWSWIRE) — Regency Centers Corporation (“Regency Centers” or the “Company”) (NASDAQ: REG) will announce its third quarter 2026 earnings results on Thursday, November 5, 2026, after the market closes. The Company’s earnings release and supplemental information package will be posted on the Investor Relations section of the Company’s website – investors.regencycenters.com. The Company will host an earnings conference call on Friday, November 6, 2026, at 11:00 a.m. ET.

Third Quarter 2026 Earnings Conference Call
Date:	Friday, November 6, 2026
Time:	11:00 a.m. ET
Dial#:	877-407-0789 or 201-689-8562
Webcast:	3rd Quarter 2026 Webcast Link
Replay
Webcast Archive: Investor Relations page under Webcasts & Presentations

About Regency Centers Corporation (NASDAQ: REG)

Regency Centers is a preeminent national owner, operator, and developer of shopping centers located in suburban trade areas with compelling demographics. Our portfolio includes thriving properties merchandised with highly productive grocers, restaurants, service providers, and best-in-class retailers that connect to their neighborhoods, communities, and customers. Operating as a fully integrated real estate company, Regency Centers is a qualified real estate investment trust (REIT) that is self-administered, self-managed, and an S&P 500 Index member. For more information, please visit RegencyCenters.com

Kathryn McKie
904 598 7348
KathrynMcKie@regencycenters.com

This press release was published by a CLEAR® Verified individual.

NESS ZIONA, Israel, Sept. 30, 2026 (GLOBE NEWSWIRE) — Foresight Autonomous Holdings Ltd. (Nasdaq and TASE: FRSX) (“Foresight” or the “Company”), an innovator in 3D perception systems, today announced that it will voluntarily delist its ordinary shares, no par value per share (the “Ordinary Shares”) from trading on the Tel Aviv Stock Exchange Ltd. (“TASE”).

“This is a natural next step for Foresight and consistent with the strategy we have begun to execute, including our recently announced plans to enter the European data-center development market”, said Haim Siboni, Chief Executive Officer and Chairman of the Board of Directors of Foresight. “Delisting from the TASE is expected to reduce cost and administrative complexity associated with maintaining a dual listing, and to allow the Company to focus its investor-relations and capital-markets resources on the Nasdaq Capital Market (“Nasdaq”), where most of the trading in our securities takes place. Israeli and international investors will continue to be able to trade the Company’s securities on Nasdaq in the form of American Depositary Shares (“ADSs”).”

The Company has requested that the TASE initiate the process to delist its Ordinary Shares. In accordance with applicable Israeli law and the rules of the TASE, the last day the Ordinary Shares will trade on the TASE will be January 1, 2027, and the Ordinary Shares will be delisted from the TASE on January 4, 2027. During the interim period, the Company’s Ordinary Shares are expected to continue to trade on the TASE.

The Company’s ADSs, each currently representing ninety (90) Ordinary Shares, will continue to be listed and trade on the Nasdaq under the symbol “FRSX.” The voluntary delisting from the TASE will not affect the Company’s listing on Nasdaq or its reporting obligations under the U.S. securities laws.

Holders of Ordinary Shares that currently trade on the TASE may convert their Ordinary Shares into ADSs through their banks or brokers. The process to convert Ordinary Shares into ADSs involves depositing Ordinary Shares in the Israeli custodian account of Bank of New York Mellon, the Depositary of the Company’s ADS program. No fractional ADSs will be issued to holders of the Company’s Ordinary Shares in connection with the conversion of their Ordinary Shares into ADSs, and the treatment of any fractional ADSs shall be in accordance with the applicable rules and instructions of the TASE.

Holders of the Company’s Ordinary Shares are encouraged to contact their banks or brokers with any questions about the conversion process.

The Company will continue to file reports with the U.S. Securities and Exchange Commission and to make public disclosures in accordance with applicable Nasdaq and U.S. securities laws.

The Company is not aware of any technical or substantive impediment to the trading of the Company’s securities on Nasdaq following its delisting from the TASE.

About Foresight

Foresight Autonomous Holdings Ltd. (Nasdaq and TASE: FRSX) is a technology company developing advanced three-dimensional (3D) perception systems and cellular-based applications. Through its wholly owned subsidiaries, Foresight Automotive Ltd., Foresight Changzhou Automotive Ltd., and Eye-Net Mobile Ltd., Foresight develops both “in-line-of-sight” vision systems and “beyond-line-of-sight” accident-prevention solutions.

Foresight’s 3D perception systems include modules of automatic calibration and dense 3D point cloud that can be applied to different markets such as automotive, defense, autonomous driving, agriculture, heavy industrial equipment, and UAVs.

Eye-Net Mobile develops next-generation vehicle-to-everything collision prevention solutions and smart automotive systems to enhance road safety and situational awareness for all road users in urban mobility environments. By leveraging cutting-edge artificial intelligence technology, advanced analytics, and existing cellular networks, Eye-Net’s innovative solution suite delivers real-time pre-collision alerts to all road users via smartphones and other smart devices within vehicles.

For more information about Foresight and its wholly owned subsidiary, Foresight Automotive, visit www.foresightauto.com, follow @ForesightAuto1 on X, or join Foresight Automotive on LinkedIn.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995 and other Federal securities laws. Words such as “aims,” “anticipates,” “expects,” “intends,” “plans,” “believes,” “seeks,” “estimates” and similar expressions or variations of such words are intended to identify forward-looking statements. For example, Foresight is using forward-looking statements in this press release when it discusses the voluntary delisting from the TASE, its strategy, the expected benefits and advantages from the delisting and the last date the Company’s Ordinary Shares will trade on the TASE and the date the Ordinary Shares will be delisted from the TASE. Because such statements deal with future events and are based on Foresight’s current expectations, they are subject to various risks and uncertainties, and actual results, performance or achievements of Foresight could differ materially from those described in or implied by the statements in this press release.

The forward-looking statements contained or implied in this press release are subject to other risks and uncertainties, including those discussed under the heading “Risk Factors” in Foresight’s annual report on Form 20-F for the fiscal year ended December 31, 2025, filed with the Securities and Exchange Commission (“SEC”) on March 25, 2026, and in any subsequent filings with the SEC. Except as otherwise required by law, Foresight undertakes no obligation to publicly release any revisions to these forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events. References and links to websites have been provided as a convenience, and the information contained on such websites is not incorporated by reference into this press release. Foresight is not responsible for the content of third party websites.

Investor Relations Contact:
Miri Segal-Scharia
CEO
MS-IR LLC
msegal@ms-ir.com

Management to meet with institutional investors at ROTH Emerging Nuclear Technology Conference, Clear Street Disruptive Technology Conference and B. Riley Convergence Conference

Conference participation supports investor outreach as Terra advances SOLO™ micro-modular reactor licensing, industrialization and commercialization initiatives

NEW YORK, Sept. 30, 2026 (GLOBE NEWSWIRE) — Terra Innovatum Global N.V. (“Terra Innovatum”, “Terra”, or the “Company”) (NASDAQ: NKLR), a developer of advanced micro-modular nuclear reactors, today announced that members of its management team will participate in three upcoming investor conferences, providing opportunities to engage with institutional investors and discuss the Company’s recent progress across licensing, industrialization and commercialization.

Terra Innovatum Announces Upcoming Investor Conference Schedule

Company to participate in ROTH Emerging Nuclear Technology Conference, Clear Street Disruptive Technology Conference and B. Riley Convergence Conference

ROTH Emerging Nuclear Technology Conference
October 1, 2026 | New York City

Terra Innovatum will participate in the inaugural ROTH Emerging Nuclear Technology Conference, an invitation-only event bringing together institutional investors and public and private companies spanning the nuclear energy ecosystem. The Company will participate in the conference’s working-lunch industry panel and hold one-on-one and small-group meetings with institutional investors.

Clear Street 2nd Annual Disruptive Technology Conference
November 18-20 | New York City

Terra Innovatum management will participate in investor meetings at Clear Street’s 2nd Annual Disruptive Technology Conference, which brings together companies and investors focused on technologies reshaping major industries and markets.

B. Riley Convergence Conference
December 2, 2026 | New York City

Terra Innovatum management will also participate in the B. Riley Convergence Conference and meet with institutional investors.

“We look forward to engaging with investors across these three conferences and discussing the progress Terra Innovatum continues to make toward bringing SOLO™ to market,” said Alessandro Petruzzi, Chief Executive Officer of Terra Innovatum. “With our NRC licensing activities advancing, our industrial and manufacturing network established, and commercial interest in reliable, scalable, zero-carbon power continuing to grow, we believe this is an important time to broaden awareness of SOLO™ and our differentiated approach to nuclear deployment.”

About Terra Innovatum and SOLO™

Terra Innovatum is developing SOLO™, a micro-modular nuclear reactor designed to provide reliable, zero-carbon power for a broad range of applications. SOLO™ is being designed around commercially available components and standard 4.95% low-enriched uranium (LEU) fuel, with a modular architecture intended to enable factory-based manufacturing and scalable deployment.

The Company is advancing SOLO™ through the U.S. Nuclear Regulatory Commission licensing process while working with an established network of industrial and manufacturing partners to support commercialization.

Terra Innovatum’s mission is to make nuclear power accessible. We deliver simple and safe micro-reactor solutions that are scalable, affordable and deployable anywhere 1 MWe at a time.

Terra Innovatum is a pioneering force in the energy sector, dedicated to delivering innovative and sustainable power solutions. Terra Innovatum plans to leverage cutting-edge nuclear technology through the SOLO™ Micro-Modular Reactor (SMR™) to provide efficient, safe, and environmentally conscious energy. With a mission to address global energy shortages, Terra Innovatum combines extensive expertise in nuclear industry design, manufacturing, and installation licensing to offer disruptive energy solutions. Committed to propelling technological advancements, Terra Innovatum and SOLO™ are dedicated to fostering prosperity and sustainability for humankind.

Conceptualized in 2018 and engineered over six years by experts in nuclear safety, licensing, innovation, and R&D, SOLO™ addresses pressing global energy demands with a market-ready solution. Built from readily available commercial off-the-shelf components, the intended licensing strategy for SOLO™ is designed to support timely deployment and minimize supply chain risks, with the aim of ensuring final cost predictability. Designed to adapt with evolving fuel options, SOLO™ supports both LEU+ and HALEU, offering a platform ready to transition to future fuel supplies.

SOLO™ will offer a wide range of versatile applications, providing CO2-free, behind-the-meter, and off-grid power solutions for data centers, mini-grids serving remote towns and villages, and large-scale industrial operations in hard-to-abate sectors like cement production, oil and gas, steel manufacturing, and mining. It also has the ability to supply heat for industrial applications and other specialized processes, including water treatment, desalination and co-generation. Thanks to its modular design, SOLO™ can be scaled to deliver up to 1GW or more of CO2-free power with a minimal footprint, making it an ideal solution for rapidly replacing fossil fuel-based thermal plants. Beyond electricity and heat generation, SOLO™ can also contribute to critical applications in the medical sector by producing radioisotopes essential for oncology research and cancer treatment.

To learn more, visit: https://investors.terrainnovatum.com/.
Follow us on X: https://x.com/TerraInnovatum
and LinkedIn: https://www.linkedin.com/company/terra-innovatum-solo/.

CONTACTS

Giordano Morichi
Founding Partner, Managing Director of Global Business Development and Investor Relations
Terra Innovatum Global N.V.
E: g.morichi@terrainnovatum.com
W: www.terrainnovatum.com

Investor and Media Relations
Simon Willcocks, Alliance Advisors IR
E: investors@terrainnovatum.com

FORWARD LOOKING STATEMENTS

This press release includes “forward-looking statements” within the meaning of the federal securities laws, including, but not limited to, opinions and projections prepared by Terra Innovatum’s management. Forward-looking statements generally relate to future events or future financial or operating performance, including pro forma and estimated financial information, and other “forward-looking statements” (as such term is defined in the Private Securities Litigation Reform Act of 1995). The recipient can identify forward-looking statements because they typically contain words such as “outlook,” “believes,” “expects,” “will,” “projected,” “continue,” “increase,” “may,” “should,” “could,” “seeks,” “predicts,” “intends,” “trends,” “plans,” “estimates,” “anticipates” or the negatives or variations of these words or other comparable words and/or similar expressions (but the absence of these words and/or similar expressions does not mean that a statement is not forward-looking).

These forward-looking statements specifically include, but are not limited to, statements regarding estimates and forecasts of financial and performance metrics, projections of market opportunity and market share, expected timing for regulatory approvals and commercialization and the potential success of Terra Innovatum’s strategy and expectations. Forward-looking statements, opinions and projections are neither historical facts nor assurances of future performance. Instead, they are based only on current beliefs, expectations and assumptions regarding the future of Terra Innovatum’s business, future plans and strategies, projections, anticipated events and trends, the economy and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside of Terra Innovatum’s control. These uncertainties and risks may be known or unknown.

Factors that may cause actual results to differ materially from current expectations include, but are not limited to: changes in domestic and foreign business, market, financial, political and legal conditions; future global, regional or local economic and market conditions; the development, effects and enforcement of laws and regulations; Terra Innovatum’s ability to manage future growth; Terra Innovatum’s ability to develop new products and services, bring them to market in a timely manner, and make enhancements to its platform; the effects of competition on Terra Innovatum’s future business; and the outcome of any potential litigation, government and regulatory proceedings, investigations and inquiries and other risks and uncertainties described under the heading “Risk Factors” in documents Terra Innovatum files from time to time with the Securities and Exchange Commission including Form 10-Q for the quarter ended June 30, 2026. If any of these risks materialize or Terra Innovatum’s assumptions prove incorrect, actual results could differ materially from the results implied by the forward-looking statements contained herein. In addition, forward-looking statements reflect Terra Innovatum’s expectations and views as of the date of this press release. Terra Innovatum anticipates that subsequent events and developments will cause its assessments to change. However, while Terra Innovatum may elect to update these forward-looking statements in the future, it specifically disclaims any obligation to do so. Accordingly, you should not place undue reliance on the forward-looking statements, which speak only as of the date they are made.